Heze Pharma

Heze Pharma is a China-based pharmaceutical R&D services company focused on drug development, registration, MAH holding and technology transfer. The company positions itself as a service platform spanning pharmaceutical research, clinical research, traditional Chinese medicine research, third-party testing and regulatory filing, with particular strength in generic drug development, consistency evaluation and product transformation. It has built a quality management system for MAH-based product holding and operation and reports holding the first drug production license issued to a pharmaceutical R&D institution in China. In addition to fee-for-service CRO-style work, Heze Pharma appears to participate selectively in product operations and investments tied to downstream commercialization. Its overall business profile is closer to an integrated pharma services and MAH platform company than a pure therapeutic biotech developer.